Missouri Baptist Medical Center Selects Vocera to Boost Patient Satisfaction

SAN JOSE, Calif. - April 22, 2014 - Vocera Communications, Inc. (NYSE: VCRA), the leading provider of integrated, intelligent communication solutions for mission-critical mobile environments, today announced that Missouri Baptist Medical Center has selected the Vocera Communication System, a set of integrated communication technology solutions that improve workflow across the hospital, enabling staff to connect with the right person, group or information easily and securely. Missouri Baptist Medical Center will use both the smartphone application and Vocera hands-free Badge to connect teams working inside and outside of the hospital, ultimately improving the patient experience.

Missouri Baptist Medical Center ranks in the top five percent of all U.S. hospitals for clinical excellence and patient safety. In order to continue achieving these standards of excellence, the 489-bed, acute-care hospital selected Vocera to provide a single channel of communication for all clinicians. Previously, nurses had to spend precious time making numerous phone calls in order to gain physician approvals, and patient calls were forced to go through a secretary before reaching the right nurse. The Vocera solution offers instant, closed-loop communication that enables faster nurse response times and more efficient workflow.

"Vocera offers our staff a smarter method of communication that reduces wait times, allowing us to spend more time providing high-quality care to our patients," said Tim Mislan, vice president and chief nursing executive at Missouri Baptist. "The Vocera solution has the potential to not only transform the way we communicate with each other, but also transform our culture."

Missouri Baptist Medical Center plans to implement Vocera for all caregivers with direct patient interaction. The technology will initially be rolled out in the hospital's emergency department in April 2014, with all other departments to follow. Over time, the hospital plans to integrate the Vocera solution into its existing nurse call system, telemetry alarms and computerized physician order entry (CPOE) system.

"Missouri Baptist has a reputation for providing outstanding patient care and the best possible outcomes," said Paul Johnson, Vocera executive vice president, sales and services. "We are honored to partner with the hospital to develop an integrated communications experience that will continue this tradition of clinical excellence and boost patient satisfaction."

About Missouri Baptist Medical Center

Missouri Baptist is a 489-bed acute-care hospital located at Highway 40 and I-270 in west St. Louis County. Recognized as a "Top 100 U.S. Hospital," "5-Star Rated for Treatment of Heart Attacks" for the tenth consecutive year in Missouri by HealthGrades and "One of America's Safest Hospitals" by Forbes, Missouri Baptist offers a full continuum of medical and surgical services, and specializes in heart, cancer, gastrointestinal, orthopedic, neurological/spine and women's health services. Missouri Baptist provided care for 22,142 inpatients and 42,112 emergency patients in 2012. Missouri Baptist Medical Center is a member of BJC HealthCare, one of the largest nonprofit healthcare organizations in the United States and the largest employer in St. Louis. Based in St. Louis, serves residents in Missouri and southern Illinois through its 13 hospitals and multiple health service organizations.

About Vocera

Vocera empowers integrated, intelligent communication in healthcare, hospitality, energy and other mission-critical mobile environments. Vocera is widely recognized for developing smarter ways to communicate that improve patient and customer satisfaction with the Vocera Communication and Care Experience solutions. Vocera provides technology innovations and thought leadership that humanize healthcare for patients, families and care teams and improve customer experience in more than 1,200 organizations worldwide. Vocera is headquartered in San Jose, Calif., with offices in Tennessee, Canada, Singapore, India and the United Kingdom. For more information, visit www.vocera.com and @VoceraCom on Twitter.

The Vocera logo is a trademark of Vocera Communications, Inc. Vocera® is a trademark of Vocera Communications, Inc. registered in the United States and other jurisdictions. All other trademarks appearing in this release are the property of their respective owners.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.